EE373 Cost-Effectiveness of Statins, Ezetimibe and PCSK9 Inhibitor for Secondary Prevention of Cardiovascular Disease
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.621
https://www.valueinhealthjournal.com/article/S1098-3015(22)00822-1/fulltext
Section Title :
Section Order :
10555
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00822-1&doi=10.1016/j.jval.2022.04.621